---
name: "Export Weaponization Geopolitical Leverage Asymmetric Vulnerability"
id: export-weaponization-geopolitical-leverage-asymmetric-vulnerability
source: 122-pharmaceutical-ingredient-dependency-ARCHITECTURE.md
system: "SW#122: pharmaceutical ingredient dependency"
category: principle
---

# Export Weaponization Geopolitical Leverage Asymmetric Vulnerability

Taiwan crisis scenario → China restricts API exports → antibiotics, blood thinners, generics unavailable → 30-90 days to critical shortages US → thousands potential mortality → India 2020 hydroxychloroquine export ban COVID panic → US cannot make basic medicines (Defense Production Act symbolic, no plants exist) → China pharmaceutical security index 85/100, US 35/100 (asymmetric leverage, negotiation impossible when dying)

## Source

Extracted from [Pharmaceutical Ingredient Dependency](#/wiki/pharmaceutical-ingredient-dependency) at line 14.
